Please login to the form below

Not currently logged in
Email:
Password:

Correction: Prexige suspended in UK, Germany and Austria

PMLive news article correction: Prexige suspended in UK, Germany and Austria

We would like to correct an article which appeared in the December 2007 issue of Pharmaceutical Marketing referring to the suspension of the arthritis drug Prexige (lumiracoxib).

In this article, we referred to this being a Bayer product; this is not the case. We would like to apologise to Bayer for our mistake and have corrected the story online.

The corrected story can be found here

11th December 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics